Higher body mass index in adults at diagnosis of the slowly progressive form of type 1 diabetes mellitus is associated with lower risk HLA genes

Diabetes Research and Clinical Practice

Volumn 104, Issue 3, 2014, Pages

  Fourlanos, S ^a,b   Elkassaby, S ^a,b   Varney, M D ^c   Colman, P G ^b   Harrison, L C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Body weight; Gene penetrance; HLA; LADA; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE 65; HLA A ANTIGEN; HLA DR ANTIGEN; INSULIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; PANCREAS ISLET BETA CELL; RISK FACTOR; WEIGHT GAIN;

BODY WEIGHT; GENE PENETRANCE; HLA; LADA; TYPE 1 DIABETES MELLITUS;

ADULT; AGED; AUTOIMMUNE DISEASES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; RISK FACTORS;

EID: 84902553904     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.03.009     Document Type: Article

References (11)

1. Couper J.J., Beresford S., Hirte C., Baghurst P.A., Pollard A., Tait B.D., et al. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 2009, 32:94-99.
2. Fourlanos S., Narendran P., Byrnes G.B., Colman P.G., Harrison L.C. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004, 47:1661-1667.
3. Betts P., Mulligan J., Ward P., Smith B., Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis'. Diabetes Med 2005, 22:144-151.
4. Xu P., Cuthbertson D., Greenbaum C., Palmer J.P., Krischer J.P. Diabetes prevention trial-type 1 study group role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007, 30:2314-2320.
5. Fourlanos S., Dotta F., Greenbaum C.K., Palmer J.P., Rolandsson O., Colman P.G., et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005, 48:2206-2212.
6. Törn C., Mueller P.W., Schlosser M., Bonifacio E., Bingley P.J. Participating laboratories diabetes antibody standardization program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008, 51:846-852.
7. Kimura A., Sasazuki T. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique. Proceedings of the 11th international histocompatibility workshop and conference 1992, Oxford University Press, Oxford. K. Tsuji, M. Aizawa, T. Sasazuki (Eds.).
8. Davis T.M., Zimmet P., Davis W.A., Bruce D.G., Fida S., Mackay I.R. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabetes Med 2000, 17:667-674.
9. Zinman B., Kahn S.E., Haffner S.M., O'Neill M.C., Heise M.A., Freed M.I. ADOPT Study Group phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 2004, 53:3193-3200.
10. Gale E.A. Spring harvest? reflections on the rise of type 1 diabetes. Diabetologia 2005, 48:2445-2450.
11. Wentworth J.M., Fourlanos S., Harrison L.C. Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat Rev Endocrinol 2009, 5:483-489.